High CD10 expression in lymph node metastases from surgically treated prostate cancer independently predicts early death

Fleischmann, Achim; Rocha, Carla; Saxer-Sekulic, Nikolina; Zlobec, Inti; Sauter, Guido; Thalmann, George N (2011). High CD10 expression in lymph node metastases from surgically treated prostate cancer independently predicts early death. Virchows Archiv, 458(6), pp. 741-8. Berlin: Springer-Verlag 10.1007/s00428-011-1084-z

[img]
Preview
Text
428_2011_Article_1084.pdf - Published Version
Available under License Publisher holds Copyright.

Download (442kB) | Preview

Patients with nodal positive prostate cancers are an important cohort with poorly defined risk factors. CD10 is a cell surface metallopeptidase that has been suggested to play a role in prostate cancer progression. CD10 expression was evaluated in 119 nodal positive prostate cancer patients using tissue microarrays constructed from primary tumors and lymph node metastases. All patients underwent radical prostatectomy and standardized extended lymphadenectomy. They had no neoadjuvant therapy and received deferred androgen deprivation. In the primary tumor, high CD10 expression was significantly associated with earlier death from disease when compared with low CD10 expression (5-year survival 73.7% vs. 91.8%; p = 0.043). In the metastases, a high CD10 expression was significantly associated with larger total size of metastases (median 11.4 vs. 6.5 mm; p = 0.015), earlier death of disease (5-year survival 71.5% vs. 87.3%; p = 0.017), and death of any cause (5-year survival 70.0% vs. 87.2%; p = 0.001) when compared with low CD10 expression. CD10 expression in the metastases added independent prognostic information for overall survival (p = 0.029) after adjustment for Gleason score of the primary tumor, nodal tumor burden, and resection margins. In conclusion, a high CD10 expression in prostate cancer predicts early death. This information is inherent in the primary tumors and in the lymph node metastases and might help to personalize patient management.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Service Sector > Institute of Pathology
04 Faculty of Medicine > Service Sector > Institute of Pathology > Clinical Pathology
04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Urology

UniBE Contributor:

Fleischmann, Achim; Rocha Perez, Carla Gabriela; Zlobec, Inti and Thalmann, George

ISSN:

0945-6317

Publisher:

Springer-Verlag

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:17

Last Modified:

23 Oct 2019 00:45

Publisher DOI:

10.1007/s00428-011-1084-z

PubMed ID:

21538124

Web of Science ID:

000291158300013

BORIS DOI:

10.7892/boris.5014

URI:

https://boris.unibe.ch/id/eprint/5014 (FactScience: 209713)

Actions (login required)

Edit item Edit item
Provide Feedback